Attached files

file filename
8-K - 8-K - WELLTOWER INC.8-K.htm
EX-99.2 - SUPPLEMENTAL INFORMATION PACKAGE - WELLTOWER INC.Exhibit99-2.htm

 

 

hcreit_logo_k_sm

 

FOR IMMEDIATE RELEASE                                                                                                      August 6, 2012

EXHIBIT 99.1                                                                                                                                    For more information contact:

                                                                                                                                                                Scott Estes (419) 247-2800

                                                                                                                                                                Jay Morgan (419) 247-2800

 

Health Care REIT, Inc.

Reports Second Quarter Results

 

Completed $1.1 billion of 2Q12 investments, 2Q12 same store cash NOI increased 4.2%

Increasing 2012 normalized FFO and FAD guidance by 1%

 

Toledo, Ohio, August 6, 2012…..Health Care REIT, Inc. (NYSE:HCN) today announced operating results for the company’s second quarter ended June 30, 2012.

 

“Health Care REIT continues to differentiate itself through the consistency of its relationship investment program, as evidenced by $602 million of second quarter investments from existing relationships.  Total investments of $1.1 billion during the quarter brings our total year-to-date investments to $1.9 billion and drives a three cent increase in our 2012 earnings expectations,” commented George L. Chapman, Chairman and Chief Executive Officer of Health Care REIT. “Our ability to source high-quality investments in the seniors housing and MOB sectors has significantly strengthened the quality of our portfolio and increased our private pay percentage.  As we move into the second half of 2012, our investment pipeline remains strong as we continue to execute our business plan.”

 

Recent Highlights

·         Completed gross new investments totaling $1.1 billion in 2Q12 including $509.5 million with Chartwell Seniors Housing REIT in May

·         Increased 2Q12 same-store cash NOI by 4.2%, including 7.4% growth in our seniors housing operating portfolio

·         Increasing 2012 normalized FFO and FAD guidance by 1%

·         Reported 2Q12 normalized FFO of $0.89 per share, and normalized FAD of $0.79 per share

·         Received $125 million in proceeds on property sales and loan payoffs, generating $32 million in gains in 2Q12 

·         Issued $600 million of 4.125% 7-year senior unsecured notes in April

·         Funded $250 million Canadian denominated unsecured term loan (approximately $249 million USD) in July

·         Completed redemptions of $100 million 7.875% Series D and $175 million 7.625% Series F preferred stock in April

·         Completed redemption/conversion of $126 million 4.75% convertible senior unsecured notes due 2026 in 2Q12 and extinguished $229 million of secured debt with a weighted average interest rate of 4.2% year-to-date

·         Announced redemption of $168 million 4.75% convertible senior unsecured notes due 2027 in June

 

Dividends for Second Quarter 2012  As previously announced, the Board of Directors declared a cash dividend for the quarter ended June 30, 2012 of $0.74 per share, as compared to $0.715 per share for the same period in 2011, representing a 3.5% increase.  The cash dividend will be paid on August 20, 2012 and will be the company’s 165th consecutive quarterly dividend payment.  The declaration and payment of quarterly dividends remains subject to review by and approval of the Board of Directors.

Page 1 of 8 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

 

Second Quarter Investment Highlights   

 

As previously announced, the company completed the acquisition with Chartwell Seniors Housing REIT (TSX:CSH.UN) of 42 seniors housing and care communities in attractive Canadian markets.  Thirty-nine of the properties are owned 50% each by the company and Chartwell. The company wholly owns the remaining three properties. Chartwell will manage the communities under an incentive-based management contract. The portfolio acquisition, comprised primarily of independent living residences, closed on May 1st.  Based on the USD to CAD exchange rate of 0.9879 on April 30th, the company’s share of the purchase price was approximately USD $509.5 million.

 

During the quarter the company completed $400 million in seniors housing triple-net lease investments at a blended yield of 7.9%.  The investments include acquisitions totaling $330 million at a blended yield of 7.8%, consisting of 14 100% private pay seniors housing facilities with four existing operators for $234 million at a blended yield of 7.3%, and seven skilled nursing/post-acute facilities with Genesis Healthcare for $96 million at a blended yield of 8.9%.  In addition, three development projects totaling $35 million at a blended yield of 8.5% were converted during the quarter and other investments (primarily comprised of capital improvements) totaling $39 million at a blended yield of 8.1% were funded.

 

During the quarter the company completed $212 million in medical office building investments at a blended yield of 7.3%.  The investments include the acquisition of seven medical office buildings for $200 million and one development conversion.  The seven buildings acquired total 739,000 rentable square feet, for an average size of 105,000 rentable square feet and yield of 7.3%.  Each building is affiliated with a health system and average occupancy is 97.3%.  The development conversion represents a 71,000 rentable square foot building that is affiliated with a health system and 100% leased with a yield of 8.0%.

 

Outlook for 2012  The company is increasing its 2012 FFO and FAD guidance by 1% to reflect investment and financing activity announced year-to-date.  Normalized FFO has been increased to a range of $3.53 to $3.63 per diluted share from $3.50 to $3.60 per diluted share and normalized FAD has been increased to a range of $3.11 to $3.21 per diluted share from $3.08 to $3.18 per diluted share. Net income attributable to common stockholders has been revised to a range of $1.07 to $1.17 per diluted share from $1.09 to $1.19 per diluted share.  The company continues to expect $300 million of dispositions in 2012 which consist primarily of non-strategic, Medicaid-oriented skilled nursing facilities. 

 

The company’s guidance does not include any additional 2012 investments beyond what has been announced, nor any additional transaction costs, capital transactions, impairments, unanticipated additions to the loan loss reserve or other additional one-time items, including any additional cash payments other than normal monthly rental payments.  Please see the exhibits for a reconciliation of the outlook for net income available to common stockholders to normalized FFO and FAD.

 

Conference Call Information  The company has scheduled a conference call on Monday, August 6, 2012 at 10:00 a.m. Eastern Time to discuss its second quarter 2012 results, industry trends, portfolio performance and outlook for 2012. Telephone access will be available by dialing 888-346-2469 or 706-758-4923 (international).  For those unable to listen to the call live, a taped rebroadcast will be available beginning two hours after completion of the call through August 20, 2012. To access the rebroadcast, dial 855-859-2056 or 404-537-3406 (international).  The conference ID number is 98945560. To participate in the webcast, log on to www.hcreit.com  15 minutes before the call to download the necessary software.  Replays will be available for 90 days.

Page 2 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

 

Key Performance Indicators

 

 

 

 

 

2Q12

 

2Q11

Change

Net income (loss) attributable to common

 

 

 

 

 

 

 

 

stockholders (NICS) per diluted share

 

$

 0.25 

 

$

 0.39 

-36%

Normalized FFO per diluted share

 

$

 0.89 

 

$

 0.90 

-1%

Normalized FAD per diluted share

 

$

 0.79 

 

$

 0.80 

-1%

Dividends per common share

 

$

 0.74 

 

$

 0.715 

3%

Normalized FFO Payout Ratio

 

 

83%

 

 

79%

 

Normalized FAD Payout Ratio

 

 

94%

 

 

89%

 

 

Quarterly Earnings

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NICS

FFO

FAD

 

 

 

 

 

 

2Q12

 

2Q11

Change

 

2Q12

 

2Q11

Change

 

2Q12

 

2Q11

Change

 

Per diluted share

 

$

 0.25 

 

$

 0.39 

-36%

 

$

 0.73 

 

$

 0.84 

-13%

 

$

 0.65 

 

$

 0.75 

-13%

 

 

Includes impact of:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on property sales(1)

 

$

 0.15 

 

$

 0.17 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other items, net(2)

 

$

 (0.15) 

 

$

 (0.06) 

 

 

$

 (0.15) 

 

$

 (0.06) 

 

 

$

 (0.15) 

 

$

 (0.06) 

 

 

 

 

Prepaid/straight-line rent receipts(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

 0.01 

 

$

 0.02 

 

 

Per diluted share - normalized(a)

 

 

 

 

 

 

 

 

$

 0.89 

 

$

 0.90 

-1%

 

$

 0.79 

 

$

 0.80 

-1%

 

(a) Amounts may not sum due to rounding

 

 

(1) $32,450,000 and $30,224,000 of gains in 2Q12 and 2Q11, respectively.

 

 

(2) See Exhibit 1.

 

 

(3) $2,123,000 and $3,102,000 of receipts in 2Q12 and 2Q11, respectively.

 

 

Supplemental Reporting Measures  The company believes that net income attributable to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), is the most appropriate earnings measurement. However, the company considers funds from operations (FFO) and funds available for distribution (FAD) to be useful supplemental measures of its operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (NAREIT) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means net income, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairments of depreciable assets, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities.   Normalized FFO represents FFO adjusted for certain items detailed in Exhibit 1.  FAD represents FFO excluding net straight-line rental adjustments, amortization related to above/below market leases and amortization of non-cash interest expenses and less cash used to fund capital expenditures, tenant improvements and lease commissions at medical office buildings.  Normalized FAD represents FAD excluding prepaid/straight-line rent cash receipts and adjusted for certain items detailed in Exhibit 1.  The company believes that normalized FFO and normalized FAD are useful supplemental measures of operating performance because investors and equity analysts may use these measures to compare the operating performance of the company between periods or as compared to other REITs or other companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items.  The company’s supplemental reporting measures and similarly entitled financial measures are widely used by investors and equity analysts in the valuation, comparison and investment recommendations of companies.  The company’s management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions.  Additionally, they are utilized by the Board of Directors to evaluate management.  The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity.  Finally, the supplemental reporting measures, as defined by the company, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.  Please see the exhibits for reconciliations of supplemental reporting measures and the supplemental information package for the quarter ended June 30, 2012, which is available on the company’s website (www.hcreit.com), for information and reconciliations of additional supplemental reporting measures.

 

 

 

 

Page 3 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

About Health Care REIT, Inc.  Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is a real estate investment trust that invests across the full spectrum of seniors housing and health care real estate.  The company also provides an extensive array of property management and development services.  As of June 30, 2012, the company’s broadly diversified portfolio consisted of 1,010 properties in 46 states and Canada.  More information is available on the company’s website at www.hcreit.com

 

Forward-Looking Statements and Risk Factors  This document may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the company’s portfolio; the sale of facilities; the performance of its operators/tenants and facilities; its ability to enter into agreements with viable new tenants for vacant space or for facilities that the company takes back from financially troubled tenants, if any; its occupancy rates; its ability to acquire, develop and/or manage facilities; its ability to make distributions to stockholders; its policies and plans regarding investments, financings and other matters; its ability to successfully manage the risks associated with international expansion and operations; its tax status as a real estate investment trust; its critical accounting policies; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; and its ability to meet its earnings guidance. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care, seniors housing and life science industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell facilities with profitable results; the failure to make new investments as and when anticipated; acts of God affecting the company’s facilities; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; regulatory approval and market acceptance of the products and technologies of life science tenants; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future acquisitions; environmental laws affecting the company’s facilities; changes in rules or practices governing the company’s financial reporting; the movement of U.S. and Canadian exchange rates; and legal and operational matters, including real estate investment trust qualification and key management personnel recruitment and retention. Finally, the company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Page 4 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

HEALTH CARE REIT, INC.

Financial Exhibits

Consolidated Balance Sheets (unaudited)

(in thousands)

 

 

 

 

 

June 30,

 

 

 

 

 

2012 

 

2011 

Assets

 

 

 

 

 

 

Real estate investments:

 

 

 

 

 

 

 

 

Land and land improvements

 

$

 1,189,280 

 

$

 983,746 

 

 

Buildings and improvements

 

 

 14,057,887 

 

 

 11,497,863 

 

 

Acquired lease intangibles

 

 

 524,145 

 

 

 347,662 

 

 

Real property held for sale, net of accumulated depreciation

 

 

 193,307 

 

 

 18,202 

 

 

Construction in progress

 

 

 170,785 

 

 

 212,161 

 

 

 

 

 

 16,135,404 

 

 

 13,059,634 

 

 

Less accumulated depreciation and intangible amortization

 

 

 (1,369,449) 

 

 

 (968,289) 

 

 

 

Net real property owned

 

 

 14,765,955 

 

 

 12,091,345 

 

 

Real estate loans receivable(1)

 

 

 300,000 

 

 

 326,651 

 

 

Less allowance for losses on loans receivable

 

 

 

 

 (1,692) 

 

 

 

Net real estate loans receivable

 

 

 300,000 

 

 

 324,959 

 

 

Net real estate investments

 

 

 15,065,955 

 

 

 12,416,304 

Other assets:

 

 

 

 

 

 

 

 

Investments in unconsolidated entities

 

 

 460,962 

 

 

 250,933 

 

 

Goodwill

 

 

 68,321 

 

 

 51,207 

 

 

Deferred loan expenses

 

 

 60,597 

 

 

 48,808 

 

 

Cash and cash equivalents

 

 

 204,895 

 

 

 328,758 

 

 

Restricted cash

 

 

 79,619 

 

 

 42,497 

 

 

Receivables and other assets(2)

 

 

 407,077 

 

 

 342,154 

 

 

 

 

 

 1,281,471 

 

 

 1,064,357 

Total assets

 

$

 16,347,426 

 

$

 13,480,661 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Borrowings under unsecured lines of credit arrangements

 

$

 393,000 

 

$

 

 

Senior unsecured notes

 

 

 4,910,871 

 

 

 4,429,992 

 

 

Secured debt

 

 

 2,299,674 

 

 

 1,889,873 

 

 

Capital lease obligations

 

 

 81,955 

 

 

 83,794 

 

 

Accrued expenses and other liabilities

 

 

 400,065 

 

 

 325,550 

Total liabilities

 

 

 8,085,565 

 

 

 6,729,209 

Redeemable noncontrolling interests

 

 

 34,068 

 

 

 18,410 

Equity:

 

 

 

 

 

 

 

 

Preferred stock

 

 

 1,022,917 

 

 

 1,010,417 

 

 

Common stock

 

 

 214,592 

 

 

 177,290 

 

 

Capital in excess of par value

 

 

 8,129,913 

 

 

 6,314,692 

 

 

Treasury stock

 

 

 (17,272) 

 

 

 (13,493) 

 

 

Cumulative net income

 

 

 2,023,769 

 

 

 1,795,448 

 

 

Cumulative dividends

 

 

 (3,309,558) 

 

 

 (2,682,479) 

 

 

Accumulated other comprehensive income

 

 

 (13,590) 

 

 

 (10,145) 

 

 

Other equity

 

 

 7,302 

 

 

 6,460 

 

 

 

Total Health Care REIT, Inc. stockholders’ equity

 

 

 8,058,073 

 

 

 6,598,190 

 

 

Noncontrolling interests

 

 

 169,720 

 

 

 134,852 

Total equity

 

 

 8,227,793 

 

 

 6,733,042 

Total liabilities and equity

 

$

 16,347,426 

 

$

 13,480,661 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes non-accrual loan balances of $12,956,000 and $9,287,000 at June 30, 2012 and 2011, respectively.

(2) Includes net straight-line receivable balances of $144,612,000 and $97,769,000 at June 30, 2012 and 2011, respectively.

                                       

Page 5 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

 

Consolidated Statements of Income (unaudited)

(in thousands, except per share data)

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

June 30,

 

June 30,

 

 

 

 

 

2012 

 

2011 

 

2012 

 

2011 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental income

 

$

 278,067 

 

$

 228,246 

 

$

 541,208 

 

$

 384,009 

 

 

Resident fees and service

 

 

 165,654 

 

 

 123,149 

 

 

 323,828 

 

 

 194,435 

 

 

Interest income

 

 

 7,879 

 

 

 12,866 

 

 

 16,020 

 

 

 24,575 

 

 

Other income

 

 

 1,482 

 

 

 5,341 

 

 

 3,166 

 

 

 8,165 

Gross revenues

 

 

 453,082 

 

 

 369,602 

 

 

 884,222 

 

 

 611,184 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 94,968 

 

 

 81,484 

 

 

 186,941 

 

 

 137,613 

 

 

Property operating expenses

 

 

 136,303 

 

 

 99,808 

 

 

 265,572 

 

 

 163,371 

 

 

Depreciation and amortization

 

 

 131,917 

 

 

 107,255 

 

 

 256,821 

 

 

 176,939 

 

 

General and administrative expenses

 

 

 25,870 

 

 

 19,562 

 

 

 53,621 

 

 

 37,276 

 

 

Transaction costs

 

 

 28,691 

 

 

 13,738 

 

 

 34,270 

 

 

 49,803 

 

 

Loss (gain) on derivatives

 

 

 (2,676) 

 

 

 

 

 (2,121) 

 

 

 

 

Loss (gain) on extinguishment of debt

 

 

 576 

 

 

 

 

 576 

 

 

 

 

Provision for loan losses

 

 

 

 

 168 

 

 

 

 

 416 

Total expenses

 

 

 415,649 

 

 

 322,015 

 

 

 795,680 

 

 

 565,418 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations before income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

and income from unconsolidated entities

 

 

 37,433 

 

 

 47,587 

 

 

 88,542 

 

 

 45,766 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax (expense) benefit

 

 

 (1,447) 

 

 

 (211) 

 

 

 (2,918) 

 

 

 (340) 

Income (loss) from unconsolidated entities

 

 

 1,456 

 

 

 971 

 

 

 2,989 

 

 

 2,514 

Income (loss) from continuing operations

 

 

 37,442 

 

 

 48,347 

 

 

 88,613 

 

 

 47,940 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (loss) on sales of properties

 

 

 32,450 

 

 

 30,224 

 

 

 33,219 

 

 

 56,380 

 

 

Impairment of assets

 

 

 

 

 

 

 

 

 (202) 

 

 

Income (loss) from discontinued operations, net

 

 

 6,983 

 

 

 7,637 

 

 

 12,497 

 

 

 13,900 

 

 

 

 

 

 

 39,433 

 

 

 37,861 

 

 

 45,716 

 

 

 70,078 

Net income (loss)

 

 

 76,875 

 

 

 86,208 

 

 

 134,329 

 

 

 118,018 

Less:

Preferred dividends

 

 

 16,719 

 

 

 17,353 

 

 

 35,926 

 

 

 26,033 

 

 

 

Preferred stock redemption charge

 

 

 6,242 

 

 

 

 

 6,242 

 

 

 

 

 

Net income (loss) attributable to noncontrolling interests

 

 

 (821) 

 

 

 (992) 

 

 

 (1,876) 

 

 

 (1,234) 

Net income (loss) attributable to common stockholders

 

$

 54,735 

 

$

 69,847 

 

$

 94,037 

 

$

 93,219 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 213,498 

 

 

 176,445 

 

 

 206,612 

 

 

 165,755 

 

 

Diluted

 

 

 215,138 

 

 

 177,488 

 

 

 208,237 

 

 

 166,458 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 0.26 

 

$

 0.40 

 

$

 0.46 

 

$

 0.56 

 

 

Diluted

 

$

 0.25 

 

$

 0.39 

 

$

 0.45 

 

$

 0.56 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common dividends per share

 

$

 0.74 

 

$

 0.715 

 

$

 1.48 

 

$

 1.405 

                                                                                       

Page 6 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

 

 

Normalizing Items

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 1

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

 

 

 

June 30,

 

  

June 30,

 

 

 

 

 

 

2012 

 

2011 

 

  

2012 

 

2011 

 

Transaction costs

 

$

 28,691 (1)

 

$

 13,738 

 

 

$

 34,270 

 

$

 49,803 

 

Special stock compensation grants

 

 

 

 

 

 

 

 4,316 

 

 

 

Loss (gain) on derivatives

 

 

 (2,676)(2)

 

 

 

 

 

 (2,121) 

 

 

 

Loss (gain) on extinguishment of debt

 

 

 576 (3)

 

 

 

  

 

 576 

 

 

 

Provision for loan losses

 

 

 

 

 

 168 

 

 

 

 

 

 416 

 

Held for sale hospital operating expenses(4)

 

 

 

 

 

 264 

 

  

 

 215 

 

 

 1,093 

 

Non-recurring other income

 

 

 

 

 (3,774) 

 

 

 

 

 

 (3,774) 

 

Preferred stock redemption charge

 

 

 6,242 (5)

 

 

 

 

 

 6,242 

 

 

 

Total

 

$

 32,833 

 

$

 10,396 

 

 

$

 43,498 

 

$

 47,538 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average diluted common shares outstanding

 

 

 215,138 

 

 

 177,488 

 

 

 

 208,237 

 

 

 166,458 

 

Net amount per diluted share

 

$

 0.15 

 

$

 0.06 

 

 

$

 0.21 

 

$

 0.29 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes:

(1) Primarily costs incurred with seniors housing and medical office building acquisitions during the quarter.

 

 

 

 

 

 

 

 

 

 

 

(2) Related to a currency hedge executed at time of commitment to Chartwell transaction to lock the exchange rate on the cash portion of the transaction.

 

 

 

 

(3) Related to redemption of convertible senior unsecured notes and secured debt extinguishments during the quarter.

 

 

 

 

(4) Represents expenses incurred in connection with a hospital previously classified as held for sale and sold in April 2012.

 

 

 

 

(5) Related to redemption of Series D and F preferred stock in April 2012.

 

 

 

 

 

 

 

                                                                                       

 

 

Funds Available for Distribution Reconciliation

 

 

 

 

 

 

 

 

 

 

 

Exhibit 2

 

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

 

 

 

June 30,

 

 

June 30,

 

 

 

 

 

 

2012 

 

2011 

 

 

2012 

 

2011 

 

 

Net income (loss) attributable to common stockholders

$

 54,735 

 

$

 69,847 

 

 

$

 94,037 

 

$

 93,219 

 

 

Depreciation and amortization(1)

 

 132,963 

 

 

 111,053 

 

 

 

 260,385 

 

 

 185,821 

 

 

Impairment of assets

 

 

 

 

 

 

 

 

 202 

 

 

Loss (gain) on sales of properties

 

 (32,450) 

 

 

 (30,224) 

 

 

 

 (33,219) 

 

 

 (56,380) 

 

 

Noncontrolling interests(2)

 

 (4,569) 

 

 

 (3,975) 

 

 

 

 (9,059) 

 

 

 (7,812) 

 

 

Unconsolidated entities(3)

 

 6,641 

 

 

 1,653 

 

 

 

 7,478 

 

 

 2,845 

 

 

Gross straight-line rental income

 

 (12,792) 

 

 

 (10,988) 

 

 

 

 (23,931) 

 

 

 (16,018) 

 

 

Prepaid/straight-line rent receipts

 

 2,123 

 

 

 3,102 

 

 

 

 3,138 

 

 

 6,713 

 

 

Amortization related to above (below) market leases, net

 

 47 

 

 

 (398) 

 

 

 

 (205) 

 

 

 (1,056) 

 

 

Non-cash interest expense

 

 2,849 

 

 

 2,698 

 

 

 

 6,542 

 

 

 6,415 

 

 

Cap-ex, tenant improvements, lease commissions

 

 (10,647) 

 

 

 (8,924) 

 

 

 

 (19,233) 

 

 

 (17,065) 

 

 

Funds available for distribution

 

 138,900 

 

 

 133,844 

 

 

 

 285,933 

 

 

 196,884 

 

 

Normalizing items, net(4)

 

 32,833 

 

 

 10,396 

 

 

 

 43,498 

 

 

 47,538 

 

 

Prepaid/straight-line rent receipts

 

 (2,123) 

 

 

 (3,102) 

 

 

 

 (3,138) 

 

 

 (6,713) 

 

 

Funds available for distribution - normalized

$

 169,610 

 

$

 141,138 

 

 

$

 326,293 

 

$

 237,709 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average diluted common shares outstanding

 

 215,138 

 

 

 177,488 

 

 

 

 208,237 

 

 

 166,458 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per diluted share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

$

 0.25 

 

$

 0.39 

 

 

$

 0.45 

 

$

 0.56 

 

 

 

Funds available for distribution

$

 0.65 

 

$

 0.75 

 

 

$

 1.37 

 

$

 1.18 

 

 

 

Funds available for distribution - normalized

$

 0.79 

 

$

 0.80 

 

 

$

 1.57 

 

$

 1.43 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Normalized FAD Payout Ratio:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends per common share

$

 0.74 

 

$

 0.72 

 

 

$

 1.48 

 

$

 1.41 

 

 

 

FAD per diluted share - normalized

$

 0.79 

 

$

 0.80 

 

 

$

 1.57 

 

$

 1.43 

 

 

 

 

Normalized FAD payout ratio

 

94%

 

 

89%

 

 

 

94%

 

 

98%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes:

(1) Depreciation and amortization includes depreciation and amortization from discontinued operations.

 

 

 

 

 

 

 

 

 

 

 

 

(2) Represents noncontrolling interests' share of net FAD adjustments.

 

 

 

 

 

 

 

 

 

 

 

 

(3) Represents HCN's share of net FAD adjustments from unconsolidated entities.

 

 

 

 

 

 

 

 

 

 

 

 

(4) See Exhibit 1.

 

 

 

 

 

 

 

 

                                                                             

Page 7 of 7 

 


 

2Q12 Earnings Release                                                                                                                                                                     August 6, 2012

 

 

 

 

Funds From Operations Reconciliation

 

 

 

 

 

 

 

 

 

 

Exhibit 3

 

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

 

 

June 30,

 

June 30,

 

 

 

 

 

 

2012 

 

2011 

 

2012 

 

2011 

 

 

Net income (loss) attributable to common stockholders

$

 54,735 

 

$

 69,847 

 

$

 94,037 

 

$

 93,219 

 

 

Depreciation and amortization(1)

 

 132,963 

 

 

 111,053 

 

 

 260,385 

 

 

 185,821 

 

 

Impairment of assets

 

 

 

 

 

 

 

 202 

 

 

Loss (gain) on sales of properties

 

 (32,450) 

 

 

 (30,224) 

 

 

 (33,219) 

 

 

 (56,380) 

 

 

Noncontrolling interests(2)

 

 (5,190) 

 

 

 (4,487) 

 

 

 (10,179) 

 

 

 (8,647) 

 

 

Unconsolidated entities(3)

 

 7,873 

 

 

 3,364 

 

 

 10,759 

 

 

 6,391 

 

 

Funds from operations

 

 157,931 

 

 

 149,553 

 

 

 321,783 

 

 

 220,606 

 

 

Normalizing items, net(4)

 

 32,833 

 

 

 10,396 

 

 

 43,498 

 

 

 47,538 

 

 

Funds from operations - normalized

$

 190,764 

 

$

 159,949 

 

$

 365,281 

 

$

 268,144 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average diluted common shares outstanding

 

 215,138 

 

 

 177,488 

 

 

 208,237 

 

 

 166,458 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per diluted share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

$

 0.25 

 

$

 0.39 

 

$

 0.45 

 

$

 0.56 

 

 

 

Funds from operations

$

 0.73 

 

$

 0.84 

 

$

 1.55 

 

$

 1.33 

 

 

 

Funds from operations - normalized

$

 0.89 

 

$

 0.90 

 

$

 1.75 

 

$

 1.61 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Normalized FFO Payout Ratio:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends per common share

$

 0.74 

 

$

 0.72 

 

$

 1.48 

 

$

 1.41 

 

 

 

FFO per diluted share - normalized

$

 0.89 

 

$

 0.90 

 

$

 1.75 

 

$

 1.61 

 

 

 

 

Normalized FFO payout ratio

 

83%

 

 

79%

 

 

85%

 

 

87%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes:

(1) Depreciation and amortization includes depreciation and amortization from discontinued operations.

 

 

 

 

 

(2) Represents noncontrolling interests' share of net FFO adjustments.

 

 

 

 

 

(3) Represents HCN's share of net FFO adjustments from unconsolidated entities.

 

 

 

 

 

(4) See Exhibit 1.

 

                                                                                       

 

 

Outlook Reconciliations: Year Ended December 31, 2012

 

 

 

 

 

 

 

 

 

 

Exhibit 4

 

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prior Outlook

 

Current Outlook

 

 

 

 

 

 

Low

 

High

 

Low

 

High

 

 

FFO Reconciliation:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to common stockholders

$

 1.09 

 

$

 1.19 

 

$

 1.07 

 

$

 1.17 

 

 

Loss (gain) on sale of properties

 

 - 

 

 

 - 

 

 

 (0.16) 

 

 

 (0.16) 

 

 

Depreciation and amortization(1)

 

 2.36 

 

 

 2.36 

 

 

 2.42 

 

 

 2.42 

 

 

Funds from operations

 

 3.45 

 

 

 3.55 

 

 

 3.33 

 

 

 3.43 

 

 

Normalizing items, net(2)

 

 0.05 

 

 

 0.05 

 

 

 0.20 

 

 

 0.20 

 

 

Funds from operations - normalized

$

 3.50 

 

$

 3.60 

 

$

 3.53 

 

$

 3.63 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FAD Reconciliation:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to common stockholders

$

 1.09 

 

$

 1.19 

 

$

 1.07 

 

$

 1.17 

 

 

Loss (gain) on sale of properties

 

 - 

 

 

 - 

 

 

 (0.16) 

 

 

 (0.16) 

 

 

Depreciation and amortization(1)

 

 2.36 

 

 

 2.36 

 

 

 2.42 

 

 

 2.42 

 

 

Net straight-line rent and above/below amortization(1)

 

 (0.22) 

 

 

 (0.22) 

 

 

 (0.22) 

 

 

 (0.22) 

 

 

Non-cash interest expense(1)

 

 0.06 

 

 

 0.06 

 

 

 0.06 

 

 

 0.06 

 

 

Cap-ex, tenant improvements, lease commissions(1)

 

 (0.26) 

 

 

 (0.26) 

 

 

 (0.25) 

 

 

 (0.25) 

 

 

Funds available for distribution

 

 3.03 

 

 

 3.13 

 

 

 2.92 

 

 

 3.02 

 

 

Normalizing items, net(2)

 

 0.05 

 

 

 0.05 

 

 

 0.20 

 

 

 0.20 

 

 

Funds available for distribution - normalized

$

 3.08 

 

$

 3.18 

 

$

 3.11 

 

$

 3.21 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes:

(1) Amounts presented net of noncontrolling interests' share and HCN's share of unconsolidated entities.

 

 

  

(2) See Exhibit 1.

 

                                                                                 

 

Page 8 of 8